Overview

Application of Desferal to Treat COVID-19

Status:
Recruiting

Trial end date:
2021-03-01

Target enrollment:

Participant gender:

Summary

In this study, defined cases of COVID-19 with mild, moderate or severe pneumonia will be treated with standard treatment regimens in combination with IV injection of Deferoxamine. Improvement in clinical, laboratory and radiological manifestations will be evaluated in treated patient compared to control group.

Phase:

Phase 1/Phase 2

Details

Lead Sponsor:

Kermanshah University of Medical Sciences

Treatments:

Deferoxamine